Mays Cancer Center at UT Health San Antonio

What Mays Cancer Center at UT Health San Antonio does

Mays Cancer Center at UT Health San Antonio is an NCI-designated academic cancer center operating since 1991 and the only such center in South Texas, one of four in Texas. It is a component of UT Health San Antonio (part of the University of Texas System) and holds an exclusive partnership with MD Anderson Cancer Center established in 2017 that provides access to MD Anderson treatment protocols, clinical trials, and second-opinion pathways. The center provides comprehensive oncology services including immunotherapy, robotic and Mohs surgery, chemotherapy (including hepatic artery infusion), radiation oncology, stem cell treatment, and targeted therapy (theranostics, Pluvicto), and manages nearly 200 active clinical trials. It maintains three core research subsidiaries: the Greehey Children's Cancer Research Institute, the Institute for Drug Development, and the Institute for Health Promotion Research.

The center's technology stack includes cryo-electron microscopy (a $5M investment in Glacios with Falcon 4 and Selectris), AI-assisted colonoscopy for polyp detection, surface guided imaging for sub-millimeter radiation therapy positioning, trans-oral robotic surgery (TORS), and hepatic artery infusion therapy. Operational research programs span cancer development and progression, experimental and developmental therapeutics, and population science and prevention, with translational pipeline activity including ERX-11/ERX-41 compounds (published in Nature Cancer with first-in-human trial potential) and MAP4K3-targeting compounds (U.S. method-of-use patent granted). Recognitions include Cardio-Oncology Center of Excellence (IC-OS) and Pheo Para Center of Excellence (Pheo Para Alliance).

Revenue is generated through a mix of patient care services billed to insurance, federal and state research grants (NCI, NIH, CPRIT, Susan G. Komen), and clinical trial participation. The center serves 38 South Texas counties, with a patient population that is more than 70% Hispanic, and runs targeted outreach programs including the Avanzando Caminos Hispanic cancer survivorship study (1,500 enrollment target) and the San Antonio Firefighters Cancer Prevention Program (serving more than 1,800 SAFD personnel). Distribution channels include in-person care, telemedicine, physician referrals, and community outreach; the center is not organized as a revenue-generating enterprise and is governed as a nonprofit component of a public academic health system.

Name

Mays Cancer Center at UT Health San Antonio

Legal name

UT Health San Antonio MD Anderson Cancer Center

Website

https://cancer.uthscsa.edu

Company type

Public

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Mays Cancer Center at UT Health San Antonio is an NCI-designated academic cancer center serving South Texas across 38 counties, partnered with MD Anderson Cancer Center, providing comprehensive oncology care, nearly 200 clinical trials, and translational research focused on the region's predominantly Hispanic population.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (62151), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Clinical Research & Trial Central Laboratories (HLAFAMAL), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Cancer treatment services
• Clinical oncology research
• Cancer clinical trials
• Radiation oncology services
• Cancer survivorship programs

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Patient Care Services: The center generates revenue through comprehensive cancer care services including chemotherapy, radiation oncology, surgery, immunotherapy, targeted therapy, and stem cell treatments provided to patients with various types of cancer.
2. Research Grants and Funding: Federal and institutional funding from NCI designation, NIH grants, CPRIT awards, and industry partnerships support research operations. Notable grants include $4.6 million NIH grant for DNA repair research, $3.3 million NIH Academic Industry Partnership grant, and $2.7 million CPRIT awards.
3. Clinical Trials: Nearly 200 clinical trials focused on cancer provide patients access to experimental treatments while generating research revenue through trial participation and industry collaborations.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Mays Cancer Center at UT Health San Antonio is an NCI-designated cancer center that provides comprehensive cancer care, including medical oncology, surgical oncology, radiation oncology, chemotherapy, immunotherapy, targeted therapy, and stem cell treatment. It manages nearly 200 cancer clinical trials, supports cancer screening and diagnosis, runs survivorship and community outreach programs, and delivers education and training in partnership with MD Anderson Cancer Center.

Product overview

Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center is an NCI-designated cancer center offering a comprehensive portfolio of cancer care services. The center provides integrated cancer treatments including immunotherapy, surgery (robotic, Mohs, reconstructive, TORS), chemotherapy (regional and hepatic artery infusion), radiation oncology, stem cell treatment, and targeted therapy (theranostics, Pluvicto). The center operates screening and diagnosis programs, manages nearly 200 clinical trials, provides survivorship care, offers education and training programs, and delivers supportive wellness services (music therapy, yoga, massage). Key programs include the San Antonio Liver Cancer Symposium, Avanzando Caminos Hispanic cancer survivor study, and San Antonio Firefighters Cancer Prevention Program. The center partners with MD Anderson Cancer Center to provide world-renowned care in South Texas.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Care and Treatment Services Comprehensive multidisciplinary cancer treatment including immunotherapy, robotic and Mohs surgery, regional and hepatic artery infusion chemotherapy, radiation oncology, stem cell treatment, and targeted therapies such as theranostics and Pluvicto, delivered to cancer patients across South Texas.
• Cancer Screening and Diagnosis Programs Early detection services covering cervical, colorectal, endometrial, HPV, hepatitis-related cancer, liver, lung, mammogram, ovarian, prostate, and skin cancer screenings for adults at risk in South Texas.
• Clinical Trials and Research Programs Access to nearly 200 cancer-focused clinical trials and research programs in cancer development and progression, experimental and developmental therapeutics, population science and prevention, drug development, and pediatric cancer research.
• Cancer Survivorship Program Clinical care and survivorship research for adult and childhood cancer survivors, addressing physical effects, social and emotional impacts, and cancer risk management.
• Education and Training Programs Cancer research training and career enhancement programs including breast oncology preceptorship, Institute for Drug Development fellowship, cancer research internship, and postbaccalaureate fellows program in cancer research.
• Community Outreach and Engagement Program Programs serving South Texas communities including the Avanzando Caminos Hispanic/Latino Cancer Survivorship Study, STAR Immunotherapy Study, San Antonio Firefighters Cancer Prevention Program, and community advisory board initiatives.

Quantifiable outcome

• One of only four NCI-designated cancer centers in Texas and the only one in South Texas
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and flagship.

• San Antonio Fire Department (SAFD)coreStrategic or Co-development Partner · 1 January 2024SAFD, with more than 1,800 fire and emergency personnel, partnered with UT Health San Antonio's Mays Cancer Center and Sylvester's Firefighter Cancer Initiative to address elevated cancer rates among local firefighters. The partnership includes an immediate response system for cancer care referrals and participation in the SAFD Wellness and Cancer Prevention Fair.
• Sylvester's Firefighter Cancer Initiative (University of Miami)coreStrategic or Co-development Partner · 1 January 2024Partnership with Sylvester Comprehensive Cancer Center's Firefighter Cancer Initiative, which began in 2015, to collaborate on the San Antonio Firefighters Cancer Prevention Program. The initiative provides expertise in occupational cancer research and prevention strategies for firefighters.
• MD Anderson Cancer CenterflagshipStrategic or Co-development Partner · 1 January 2017In 2017, Mays Cancer Center became one of a select few centers in the nation partnering with MD Anderson Cancer Center. This highest-level partnership provides access to MD Anderson's treatment protocols, standards of care, clinical trials, and translational research. The partnership enables coordination on complex cases, seamless second opinions, and facilitated access to MD Anderson clinical trials for eligible patients.
• Evestra Inc.coreStrategic or Co-development PartnerSan Antonio-based biopharmaceutical company partnered with Mays Cancer Center on a five-year, $3.3 million NIH Academic Industry Partnership grant for ovarian cancer drug development.
• SignalRx Pharmaceuticals Inc.coreStrategic or Co-development PartnerPartnership with SignalRx Pharmaceuticals for development of dual- or triple-targeted anti-cancer drugs. Daruka Mahadevan, MD, together with SignalRx, secured two NCI business grants (approximately $300,000) for drugs on pathway to first-in-human clinical trials targeting lung, pancreatic, and breast cancer, and lymphoma.
• UT Health San Antonio Institute for Health Promotion ResearchcoreStrategic or Co-development PartnerThe Institute for Health Promotion Research at UT Health San Antonio leads community outreach for the Firefighters Cancer Prevention Program and conducts cancer disparities research, including the Avanzando Caminos Hispanic cancer survivorship study enrolling 1,500 participants.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Fox Chase Cancer Center: NCI-designated cancer center in Philadelphia that recently hired one of Mays Cancer Center's breast medical oncologists. Direct peer in translational research, NCI funding competition, and academic cancer care delivery.
• UT Southwestern Harold C. Simmons Comprehensive Cancer Center: One of the four NCI-designated cancer centers in Texas, located in Dallas. Operates as a direct peer competing for NCI Cancer Center Support Grant funding, faculty recruitment, CPRIT awards, and North Texas patient referrals within the same UT System structure.
• Roswell Park Comprehensive Cancer Center: One of the original NCI-designated comprehensive cancer centers in the United States, located in Buffalo, NY. Comparable mid-sized academic cancer center with similar NCI designation standing, clinical trial infrastructure, and translational research focus.
• Huntsman Cancer Institute: NCI-designated cancer center at the University of Utah. Comparable academic cancer center with similar community outreach programs, rural catchment population, and translational research capabilities anchored by an independent research institute structure.
• Sylvester Comprehensive Cancer Center: NCI-designated cancer center at the University of Miami and direct partner on the San Antonio Firefighters Cancer Prevention Program through its Sylvester Firefighter Cancer Initiative. Comparable academic cancer center structure with similar community outreach focus on occupational and minority health disparities.
• Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center: NCI-designated cancer center in Houston, Texas, and one of four NCI centers in the state. Direct peer in competing for federal research funding, clinical trial enrollments, and Texas oncology market share, with overlapping specialty programs in breast and pediatric oncology.

Broad incumbents

• Dana-Farber Cancer Institute: NCI-designated comprehensive cancer center affiliated with Harvard Medical School. Comparable translational research pipeline, drug development capabilities, and academic cancer care focus, though at significantly larger national scale.
• MD Anderson Cancer Center: The University of Texas MD Anderson Cancer Center in Houston is the flagship MD Anderson partnership for Mays Cancer Center and the dominant NCI-designated cancer center in Texas. It provides protocols, clinical trials, and translational research access, and serves as both a partner and the primary competitor for Texas oncology referrals.
• Memorial Sloan Kettering Cancer Center: One of the largest and most prestigious NCI-designated cancer centers in the U.S. Comparable comprehensive cancer care portfolio and research output, though operating at materially larger national scale than Mays Cancer Center.

Regional players

• Livestrong Cancer Institutes (UT Austin Dell Medical School): Texas-based cancer care program at UT Austin, comparable in geographic concentration and academic structure. While not NCI-designated at the comprehensive cancer center level, it competes for Texas oncology talent, patient referrals, and CPRIT state funding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mayscancer
• YouTubeyoutube.com/@mayscancercenter
• Facebookfacebook.com/mayscancercenter
• LinkedInlinkedin.com/company/mays-cancer-center
• Instagraminstagram.com/mayscancercenter

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mays Cancer Center at UT Health San Antonio